A substantial 52-member Pakistani delegation, spearheaded by the Pakistan China Joint Chamber of Commerce and Industry (PCJCCI) and Hameed Latif Healthcare Group, today arrived in the People’s Republic of China to participate in ASPIRE 2026, aiming to significantly bolster bilateral healthcare collaboration, particularly in advanced reproductive medicine.
The delegation”s involvement in ASPIRE 2026, taking place from 7th to 10th May at the China National Convention Center, underscores a pivotal moment for medical cooperation. The congress, themed ‘Journeying the Silk Road of Reproductive Care,’ convenes global experts to share insights on cutting-edge fertility treatments, reproductive technologies, and patient-centred care models.
Haroon Latif Khan, Chairman of the Standing Committee on Health Services at PCJCCI, is leading the delegation. His leadership highlights the burgeoning alliance between institutional platforms and private healthcare stakeholders to foster international collaboration and medical progress.
Nazir Hussain, President PCJCCI, articulated that this joint endeavour with Hameed Latif Healthcare Group signifies a major landmark in strengthening Pakistan-China cooperation within the health sector. He emphasised that attending ASPIRE 2026 will grant Pakistani professionals access to international knowledge systems, sophisticated medical technologies, and global institutional networks.
Such engagements are crucial for modernising Pakistan’s healthcare infrastructure, improving service delivery, and elevating patient outcomes, especially in specialised domains like reproductive medicine, Mr. Hussain added.
Mr. Khan underscored that this participation offers a strategic chance for Pakistan to align its reproductive healthcare sector with global benchmarks. He noted that exposure to advanced assisted reproductive technologies (ART), clinical innovations, and international best practices would considerably enhance fertility care capabilities in Pakistan.
He further elaborated that this interaction would pave the way for collaborative research, training initiatives, and technology transfer with Chinese and other international partners. The collaboration ensures direct exposure for Pakistani healthcare professionals to the latest advancements in reproductive medicine and fertility management, ultimately strengthening clinical expertise and elevating treatment standards nationwide.
The initiative is also anticipated to forge new institutional partnerships, joint research ventures, and investment prospects in healthcare infrastructure. Engagements scheduled in Beijing and Shanghai will facilitate discussions on future cooperation, encompassing joint ventures, training programmes, and the establishment of specialised medical centres across Pakistan.